Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Home›Companies›Smith & Nephew
Smith & Nephew logo

Smith & Nephew

Life Unlimited.
Watford, United Kingdom MedTech 18,000 employees Founded 1856 SN smith-nephew.com ↗
8 Products & services
1 Licensed medicines
23 Clinical trials
2 FDA device clearances
18,000 Employees

About Smith & Nephew

Smith & Nephew is a British multinational medical-devices company headquartered in Watford, focused on orthopaedics, sports medicine and advanced wound management.

Sector
MedTech
Headquarters
Watford, United Kingdom
Founded
1856
Employees
18,000

Milestones

Milestones as listed on smith-nephew.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

1856
Thomas James Smith opens a chemist shop in Hull
He also developed a new way to refine cod liver oil.
Source: smith-nephew.com
1896
Partnership forms TJ Smith & Nephew
Horatio Smith went into partnership with his uncle.
Source: smith-nephew.com
1907
Smith & Nephew becomes a limited company
Source: smith-nephew.com
1921
First independent overseas branch opens in Canada
Source: smith-nephew.com
1937
Listed on the London Stock Exchange
Source: smith-nephew.com
1986
Acquires Richards Medical and DYONICS
Added an orthopaedics specialist and an arthroscopy specialist, both US-based.
Source: smith-nephew.com
1995
Acquires Acufex Microsurgical; listed on NYSE
Made the company a market leader in arthroscopic surgical devices.
Source: smith-nephew.com
2001
Joins FTSE 100; OXINIUM introduced
OXINIUM is a material that extends the life of joint replacement systems.
Source: smith-nephew.com

Leadership Team

Leadership as listed on smith-nephew.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

Deepak Nath

Chief Executive Officer
Source: smith-nephew.com

Vasant Padmanabhan

President Research & Development and ENT
Source: smith-nephew.com

Helen Barraclough

Group General Counsel and Company Secretary
Source: smith-nephew.com

Paul Connolly

President Global Operations
Source: smith-nephew.com

Products & Services

Products and services as listed on smith-nephew.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.

All Advanced wound management Sports medicine Orthopaedic robotics Orthopaedics Ear, nose and throat
Advanced wound management

ALLEVYN COMPLETE CARE

Foam dressings listed among top products.

Source: smith-nephew.com
Advanced wound management

RENASYS EDGE

Negative pressure wound therapy system.

Source: smith-nephew.com
Sports medicine

REGENETEN Bioinductive Implant

Implant for partial-thickness rotator cuff tears that supports tendon healing without sutured repair.

Source: smith-nephew.com
Sports medicine

CARTIHEAL AGILI-C Cartilage Repair Implant

Porous implant for single-stage repair of knee cartilage and osteochondral defects.

Source: smith-nephew.com
Orthopaedic robotics

CORI Surgical System

Handheld robotics platform, launched in 2020.

Source: smith-nephew.com
Orthopaedics

JOURNEY II ROX Total Knee Solution

Knee replacement system offered with CONCELOC and OXINIUM technologies.

Source: smith-nephew.com
Ear, nose and throat

Tula Tympanostomy System

ENT system for tympanostomy (ear tube) procedures.

Source: smith-nephew.com
Ear, nose and throat

COBLATION

Technology used for airway management.

Source: smith-nephew.com

Pipeline & Regulatory Record

What public registers list for Smith & Nephew: clinical trials it sponsors, FDA device clearances, Irish licences, recent approvals and supply shortages. Rebuilt daily, last on 10 Oct 2026.

23Trials as lead sponsor
8Recruiting now
0With a site in Ireland
2FDA device clearances

Clinical trials 23 in our ClinicalTrials.gov registers

StudyPhaseStatus
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
NCT06564636 · Total Hip Arthroplasty (THA), Osteoarthritis
ObservationalActive, closed
A Global Clinical Study Investigating the Safety and Effectiveness of Smith and Nephew's Porous Knee System in Patients Who Need a Total Knee Replacement Due to Degenerative Arthritis, Post-traumatic Arthritis or Inflammatory Arthritis
NCT05197036 · Osteoarthritis, Post-traumatic Arthritis
ObservationalActive, closed
Safety and Effectiveness Study of OR3O™ Dual Mobility System in THA
NCT04325022 · Advanced Degeneration of the Hip Joint, Revision of the Hip Joint
ObservationalActive, closed
Safety and Performance Study of the Legion Porous System in Total Knee Arthroplasty
NCT03720782 · Total Knee Arthroplasty
ObservationalActive, closed
Safety and Efficacy of the ANTHEM™ CR Total Knee System
NCT03885622 · Non-inflammatory Degenerative Joint Disease
ObservationalActive, closed
Safety and Performance Using Legion™ CR Oxinium and CoCr Femoral Implants Combined With Legion™/Genesis™ II XLPE High Flex Tibial Inserts
NCT03687593 · Total Knee Arthroplasty
ObservationalActive, closed
JOURNEY II XR Safety and Effectiveness PMCF
NCT03136887 · Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee, Unilateral Post-Traumatic Osteoarthritis of Knee
ObservationalActive, closed
Ten Year Implant Survivorship of the ANTHEM™ PS Total Knee System
NCT03078543 · Arthroplasty, Replacement, Knee
ObservationalActive, closed
JOURNEY™ II CR Total Knee System
NCT02440672 · Osteoarthritis, Knee
ObservationalActive, closed
Post Market Clinical Follow Up of LEGION™ Primary TKS With VERILAST™
NCT02380092 · Degenerative Joint Disease
ObservationalActive, closed

Showing 10 of 23, trials with Irish sites first. The full lists are on the sponsor pages below.

All trials by sponsor name 1 registry name

FDA 510(k) device clearances 2

Clearances in our FDA device register: every clearance to an Irish-based applicant, plus the last 90 days worldwide.

Group (Smith & Nephew): founded 1856, headquarters London, website smith-nephew.com. Wikidata Q502509 · Wikipedia. From Wikidata (CC0), matched by the group's Legal Entity Identifier.

How this is matched: register records are linked to this page by the organisation name they carry, here Smith & Nephew Orthopaedics AG; Smith & Nephew, Inc.; Smith & Nephew Pte Ltd; Smith & Nephew Medical, Ltd.; Smith & Nephew GmbH. Spot a wrong match? Tell us.

Financials & Irish Entities

From the annual reports Smith & Nephew plc files with the US Securities and Exchange Commission (20-F, IFRS), in USD as reported. Latest financial year: to Dec 2025.

$6.2bnRevenue
$296mR&D expense
4.8%R&D as % of revenue
$625mNet income (10.1% margin)
Revenue and R&D expense, USD bn$0.0bn$2.0bn$4.0bn$6.0bn$8.0bnDec 2021Dec 2022Dec 2023Dec 2024Dec 2025Dec 2021: $5.2bn (Revenue)Dec 2022: $5.2bn (Revenue)Dec 2023: $5.6bn (Revenue)Dec 2024: $5.8bn (Revenue)Dec 2025: $6.2bn (Revenue)RevenueDec 2021: $0.4bn (R&D expense)Dec 2022: $0.4bn (R&D expense)Dec 2023: $0.3bn (R&D expense)Dec 2024: $0.3bn (R&D expense)Dec 2025: $0.3bn (R&D expense)R&D expense
RevenueR&D expense
Year toRevenueR&DR&D %Net incomeFiling
Dec 2025$6.16bn$296m4.8%$625m20-F 2026
Dec 2024$5.81bn$289m5.0%$412m20-F 2026
Dec 2023$5.55bn$339m6.1%$263m20-F 2026
Dec 2022$5.22bn$345m6.6%$223m20-F 2025
Dec 2021$5.21bn$356m6.8%$524m20-F 2024

Each year is taken from the most recent annual report that includes it, so earlier years reflect any later restatement. Source: SEC EDGAR (XBRL financial data). Compare companies on the pharma company financials register.

Companies registered in Ireland 1 active in the CRO register

CompanyCRO no.RegisteredLast accounts
Smith & Nephew (Ireland) Trading Limited
LTD - Private Company Limited by Shares
85961933Dec 2024

From the Companies Registration Office (CRO Open Data, CC BY 4.0). A company is listed when GLEIF's legal entity register links it to Smith & Nephew plc as its ultimate parent, or when we checked its name and registered address by hand. Branches of foreign companies appear as "External company". Spot a missing or wrong entry? Tell us.

In the News

No coverage yet — our newsroom tracks Smith & Nephew continuously.

Research Publications

EUROPE PMC · LIVE
Searching Europe PMC for affiliated publications...

FDA Recalls (US)

OPENFDA · LIVE
Checking openFDA drug-recall records...